IsovolumeFEF25-75% 6 and FEV1 for identifying bronchodilator response Source: Eur Respir J 2006; 28: Suppl. 50, 156s Year: 2006
Comparison of bronchodilatator response of FEV1 and airway resistance Source: Annual Congress 2003 - Assessing airway function: practicalities and clinical applications Year: 2003
Immediate bronchodilator response in FEV1 as a diagnostic criterion for adult asthma Source: Eur Respir J, 53 (2) 1800904; 10.1183/13993003.00904-2018 Year: 2019
Closing volume predicts the FEV1 response to bronchodilators in patients with COPD Source: Virtual Congress 2020 – Advances in lung function testing Year: 2020
Influence of basal FEV1 on the response to bronchodilator agents in COPD Source: Eur Respir J 2001; 18: Suppl. 33, 426s Year: 2001
Normal lung function and absence of bronchodilator response in children with stable, controlled asthma using inhaled corticosteroids Source: Annual Congress 2006 - New features of paediatric asthma Year: 2006
Maximally attained level of FEV1 and FEV1 decline determine airway hyperresponsiveness in adults Source: Eur Respir J 2003; 22: Suppl. 45, 17s Year: 2003
Immediate bronchodilation response in FEV1 as a diagnostic criterion of adult asthma Source: International Congress 2018 – Clinical markers of asthma Year: 2018
Comparison of FEV1 and PEF values in cough variant asthma during methacholine challenge test Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010
FEF25-75% should not yet be used to define a bronchodilator response in individuals Source: Annual Congress 2005 - Spirometry - now and in the future Year: 2005
Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012
Time of maximal spirometric change after bronchodilator inhalation Source: International Congress 2017 – Discussion of techniques and technologies in lung function Year: 2017
Does an acute FEV1 response predict long-term improvements with bronchodilators in patients with COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001
sGaw as an alternative for FEV1 in the measurement of airway responsiveness to methacholine in patients experiencing chronic cough Source: Annual Congress 2011 - Lung function today and tomorrow I Year: 2011
Basal FEV1 does not predict the long term response to salmeterol/fluticasone in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 342s Year: 2004
Baseline FEV1 and sputum neutrophils and macrophages predict the decrease in FEV1 after inhaled corticosteroid withdrawal in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 306s Year: 2004
Bronchyal hyperreactivity estimated by bronchodilatator test and FEF25-75/FVC ratio Source: Eur Respir J 2007; 30: Suppl. 51, 744s Year: 2007
Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV1 and FEV1 in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005
The role of forced partial expiratory flows to test the bronchodilator response in COPD Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights Year: 2012
Airway calibre variability by forced oscillation technique: a sensitive indicator of bronchodilator effect in asthmatic children Source: Annual Congress 2005 - Monitoring paediatric asthma Year: 2005